Cargando…

Continuing Education

Detalles Bibliográficos
Autores principales:	Lipsy, Robert J., Fuller, Mark G., Mansukani, Sharad, Roski, Joachim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2004
Materias:	Cea
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438315/ https://www.ncbi.nlm.nih.gov/pubmed/15253683 http://dx.doi.org/10.18553/jmcp.2004.10.S3-a.S17

Ejemplares similares

Part1 How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider Relations
por: Lipsy, Robert J., et al.
Publicado: (2004)

Anticipating the Future: How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider Relations
por: Lipsy, Robert J., et al.
Publicado: (2004)

Preview Overview
por: Lipsy, Robert J.
Publicado: (2004)

Overview of Pharmacologic Therapy for the Treatment of Dyslipidemia
por: Lipsy, Robert J.
Publicado: (2003)

Introduction
por: Lipsy, Robert J.
Publicado: (2003)

Continuing Education
por: Carter, Barry L., et al.
Publicado: (2004)

Continuing Education
por: Chrischilles, Elizabeth A., et al.
Publicado: (2003)

Continuing Education
por: Meltzer, Eli O., et al.
Publicado: (2003)

Developing a Collaborative Study Protocol for Combining Payer-Specific Data and Clinical Trials for CER
por: Sanchez, Robert J., et al.
Publicado: (2011)

Introduction
por: Cziraky, Mark J.
Publicado: (2008)

Introduction
por: Mullins, C. Daniel, et al.
Publicado: (2011)

Considerations on the Use of Patient-Reported Outcomes in Comparative Effectiveness Research
por: Alemayehu, Demissie, et al.
Publicado: (2011)

The Impact of Residual Cardiovascular Risk in Combination Lipid-Modifying Therapy in the Managed Care Setting
por: Talbert, Robert L.
Publicado: (2008)

Looking at CER from the Pharmaceutical Industry Perspective
por: Dubois, Robert W.
Publicado: (2012)

Managing the Intersection of Medical and Pharmacy Benefits
por: McDonald, Robert C.
Publicado: (2008)

Health Information Technology—Results From a Roundtable Discussion
por: Balfour, Donald C., et al.
Publicado: (2009)

The Future of Medicare Part D Drug Plans—Results From a Roundtable Discussion
por: Balfour III, Donald C., et al.
Publicado: (2009)

Narrative Review of the Literature on Adherence to Disease-Modifying Therapies Among Patients with Multiple Sclerosis
por: Menzin, Joseph, et al.
Publicado: (2013)

Emerging Trends for Prevention and Treatment of Diabetic Nephropathy
por: Hunsicker, Lawrence G.
Publicado: (2004)

Improving Cost-Effectiveness of and Outcomes From Drug Therapy in Patients With Atrial Fibrillation in Managed Care: Role of the Pharmacist
por: Johnson, Samuel G.
Publicado: (2009)

A Call to Action
por: Thompson, Tommy G.
Publicado: (2006)

AMCP’s Framework for Quality Drug Therapy
por: Avery, Steven G.
Publicado: (2005)

Treatment-Resistant Depression: Managed Care Considerations
por: Tierney, John G.
Publicado: (2007)

Challenges Facing Employers in the Treatment of Depression
por: Avery, Steven G.
Publicado: (2005)

Multiple Myeloma: Supportive Care Requirements and Coordination of Patient-Centered Care
por: Bugos, Kelly G., et al.
Publicado: (2012)

Statistical Issues with the Analysis of Nonrandomized Studies in Comparative Effectiveness Research
por: Alemayehu, Demissie, et al.
Publicado: (2011)

Successful HIV Treatment
por: Cohen, Calvin J.
Publicado: (2006)

Introduction
por: Sax, Michael J.
Publicado: (2005)

Value-Based Benefit Design: Using a Predictive Modeling Approach to Improve Compliance
por: Mahoney, John J.
Publicado: (2008)

Essential Steps and Practical Applications for Database Studies
por: Sax, Michael J.
Publicado: (2005)

Disease Progression and the Application of Evidence-Based Treatment Guidelines Diagnose It Early: A Case for Screening and Appropriate Management
por: Manley, Harold J.
Publicado: (2007)

Evidence Based Medicine Health Care's Next Holy War
por: Kleinke, J.D.
Publicado: (2005)

Not Getting to Goal: The Clinical Costs of Noncompliance
por: Ansell, Benjamin J.
Publicado: (2008)

The Importance and Impact of Evidence Based medicine
por: Lewis, Sonya J., et al.
Publicado: (2004)

Days of Prophylactic Filgrastim Use to Reduce Febrile Neutropenia in Patients
por: Scott, Shane J., et al.
Publicado: (2003)

“Ten Commandments” for Conducting Comparative Effectiveness Research Using “Real-World Data”
por: Willke, Richard J., et al.
Publicado: (2011)

Introduction
por: kleinke, J.D., et al.
Publicado: (2005)

Emerging Methods for Evaluating the Effectiveness of Intramuscular Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis
por: Foley, John F., et al.
Publicado: (2013)

Implementing the New Guidelines for Hypertension
por: Carter, Barry L.
Publicado: (2004)

Pharmacoeconomic Challenges in the Management of Diabetic Nephropathy
por: Rodby, Roger A.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_ap5vovo1g1h9m6edbe62q02kcu